How Gut Bacteria Turn Red Meat into a Heart Risk

Trimethylamine N-oxide (TMAO): how gut bacteria convert nutrients from red meat and eggs into a cardiovascular risk factor — and how to reduce your levels naturally.

When gut bacteria in your digestive tract encounter choline, L-carnitine, or betaine — nutrients abundant in red meat, eggs, and certain supplements — they convert them into a chemical called trimethylamine (TMA). Your liver then oxidizes TMA into TMAO (trimethylamine N-oxide), which circulates in your blood. Research from the Cleveland Clinic and multiple independent cohorts has established that elevated TMAO levels substantially increase the risk of heart attack, stroke, and cardiovascular death — even after accounting for traditional risk factors like cholesterol and blood pressure [1][3][5]. What makes TMAO particularly interesting is that your gut microbiome composition largely determines how much you produce, creating wide individual variation even among people eating identical diets [2].

The TMAO Pathway: Diet, Bacteria, and Your Liver

TMAO production follows a three-step process rooted in the interaction between what you eat and who lives in your gut.

Step 1 — Dietary precursors: You eat foods containing choline (eggs, liver, red meat), betaine (beets, spinach, wheat germ), L-carnitine (red meat, heart), or phosphatidylcholine (lecithin supplements, egg yolks). These are all essential or beneficial nutrients in other contexts.

Step 2 — Bacterial conversion: Gut bacteria — particularly species within Firmicutes and certain Proteobacteria — carry TMA lyase enzymes that cleave the trimethylamine group from these nutrients, producing TMA gas in the gut.

Step 3 — Liver oxidation: TMA is absorbed into your bloodstream and transported to the liver, where an enzyme called FMO3 (flavin-containing monooxygenase 3) oxidizes it into TMAO. TMAO then circulates systemically.

How TMAO Damages Arteries

TMAO promotes atherosclerosis through several converging mechanisms [1]:

Macrophage foam cell formation: TMAO upregulates scavenger receptors on macrophages, causing them to accumulate cholesterol and transform into foam cells that accumulate in artery walls.
Inhibited reverse cholesterol transport: TMAO impairs the body's ability to move cholesterol out of arteries and back to the liver for excretion.
Platelet hyperreactivity: TMAO sensitizes platelets to aggregation signals, increasing the risk of blood clots forming on top of plaques.
Vascular inflammation: TMAO activates inflammatory signaling in blood vessel walls.

Why Two People Can Eat the Same Meal and Produce Very Different TMAO

Gut microbiome composition is the critical variable. Omnivores typically produce far more TMAO from an L-carnitine challenge than vegans and vegetarians, because plant-based diets select for microbial communities with less TMA lyase activity [2]. This means red meat carries different cardiovascular implications depending on who is eating it. Long-term dietary patterns reshape the microbiome, which in turn reshapes TMAO production capacity.

Foods That Raise TMAO Precursors

Red meat (beef, lamb, pork) — richest sources of L-carnitine and carnitine-derived nutrients
Egg yolks — concentrated phosphatidylcholine
Full-fat dairy — moderate choline content
Liver and organ meats — high in both choline and carnitine
Lecithin supplements — provide concentrated phosphatidylcholine directly

Fish naturally contain preformed TMAO, but the cardiovascular evidence on fish is complex. The omega-3 fatty acids, astaxanthin, and other beneficial compounds in oily fish appear to offset or counterbalance TMAO's effects, which may help explain why fish consumption is generally not associated with increased cardiovascular risk despite high TMAO content.

Natural Approaches to Reduce TMAO

Resveratrol: Found in dark grapes, berries, pomegranate, and dark chocolate, resveratrol reduces TMAO levels by remodeling gut microbiota — increasing Lactobacillus and Bifidobacterium while suppressing TMA-producing strains, and enhancing bile acid deconjugation which reduces precursor recycling [4]. See our resveratrol page for more on this molecule.

Mediterranean diet patterns: Higher vegetable, legume, olive oil, and polyphenol intake consistently associates with lower TMAO levels in population studies. Multiple mechanisms are likely at play, including fiber-driven microbiome shifts and direct TMA lyase inhibition.

3,3-Dimethyl-1-butanol (DMB): This compound, naturally present in cold-pressed olive oil and grape seed oil, directly inhibits TMA lyase — the bacterial enzyme that generates TMA from choline and carnitine. This may partly explain olive oil's well-established cardiovascular benefits beyond its monounsaturated fat content.

Prebiotic fiber: High dietary fiber intake shifts the gut microbiome toward fiber-fermenting species that don't produce TMA, effectively diluting TMA-producing populations. Diversity in plant foods is especially valuable here.

Fermented foods: Foods containing Lactobacillus and Bifidobacterium (kefir, yogurt, kimchi, sauerkraut) support microbial populations that compete with TMA producers. See our fermented foods pages for practical guidance.

Reducing red meat without eliminating it: Even modest reductions in red meat frequency — particularly processed and conventionally raised varieties — can meaningfully lower TMAO exposure.

Practical Takeaway

TMAO is not a reason to fear eggs or avoid all red meat, but it is a reason to pay attention to overall dietary patterns. A gut microbiome shaped by abundant plant diversity, fermented foods, and polyphenol-rich foods will generate far less TMAO from a given steak than one shaped by a low-fiber, high-red-meat diet. The Mediterranean dietary pattern — not elimination of any specific food — represents the best-evidenced approach to keeping TMAO in check.

Evidence Review

The Discovery: Cleveland Clinic's 2011 Nature Study

Wang et al. [1] conducted the foundational investigation using untargeted metabolomics to identify plasma markers distinguishing cardiovascular disease patients from controls. They identified choline, betaine, and TMAO as strongly predictive metabolites. Crucially, they used germ-free mouse models to establish that TMAO production required an intact gut microbiome — germ-free mice fed choline-rich diets produced virtually no TMAO and developed significantly less atherosclerosis than conventionally housed mice on identical diets. When gut microflora were suppressed with antibiotics in atherosclerosis-prone mice, dietary-choline-enhanced atherosclerosis was substantially reduced. This provided mechanistic confirmation that TMAO is a gut microbiome-dependent cardiovascular risk factor, not simply a dietary biomarker.

Red Meat, L-Carnitine, and the Microbiome: 2013 Nature Medicine

Koeth et al. [2] extended the framework to L-carnitine, examining 2,595 adults undergoing cardiac evaluation. Plasma L-carnitine independently predicted major adverse cardiac events (MACE: myocardial infarction, stroke, or death), but the association was substantially stronger — and reached statistical significance — only among individuals with concurrently elevated TMAO levels. This conditional relationship implicated gut microbiota metabolism as the key mechanistic link, not L-carnitine per se.

In a dietary challenge arm, omnivorous humans produced robust TMAO responses to an L-carnitine dose; vegans and vegetarians produced near-zero TMAO from the same dose. Following antibiotic suppression of gut flora, TMAO production was abolished in omnivores, confirming microbiome dependence. The study also found that among 77 healthy subjects, higher habitual red meat intake correlated with greater TMAO production from a carnitine challenge, consistent with meat consumption progressively selecting for TMA-producing microbiota.

Quantifying Human Cardiovascular Risk: 2013 NEJM Study

Tang et al. [3] published what remains the most-cited study on TMAO and cardiovascular outcomes, examining 4,007 adults undergoing elective diagnostic cardiac catheterization and followed for a median of 3 years. Key findings:

Plasma TMAO levels predicted incident MACE with a hazard ratio of 2.54 for the highest vs. lowest TMAO quartile (95% CI: 1.96–3.28, p<0.001)
The association persisted after adjustment for traditional cardiac risk factors, kidney function, C-reactive protein, and medication use
Elevated choline and betaine also predicted cardiovascular risk, though with somewhat attenuated effect sizes compared to TMAO
The predictive relationship held within subgroups stratified by LDL cholesterol, diabetes status, and prior statin use

This study also confirmed the mechanistic model: supplemental phosphatidylcholine raised TMAO significantly in omnivorous participants but minimally in those on antibiotics, and minimally in long-term vegans without antibiotic treatment.

Predicting Risk in Healthy People: EPIC-Norfolk

Tang et al. [5] applied TMAO analysis to the community-based EPIC-Norfolk prospective cohort — 2,242 apparently healthy middle-aged adults without established cardiovascular disease at baseline. Over a median 14-year follow-up:

Higher baseline plasma TMAO significantly predicted incident coronary artery disease independent of traditional risk factors
Plasma choline also independently predicted incident CAD
The predictive value was maintained after adjustment for dietary patterns, including fish intake — addressing the confounding concern that TMAO elevation in fish-heavy diets might create false risk signals

The EPIC-Norfolk findings are important because they demonstrate TMAO's predictive utility in primary prevention populations, not only in high-risk clinical cohorts.

Resveratrol and Microbiome Modulation

Chen et al. [4] investigated whether resveratrol's anti-atherosclerotic effects involved TMAO modulation in ApoE-knockout (atherosclerosis-prone) mice fed a TMAO-supplemented diet. Resveratrol supplementation:

Reduced circulating TMAO levels by approximately 50%
Attenuated atherosclerotic lesion development in the aortic root
Increased Lactobacillus and Bifidobacterium populations in gut microbiota
Enhanced bile salt hydrolase activity, which promoted bile acid deconjugation and fecal excretion — reducing bile acid recirculation and TMAO precursor availability

While animal models don't translate directly to human outcomes, this study provided a plausible mechanistic pathway through which polyphenol-rich foods might reduce TMAO-driven cardiovascular risk.

Evidence Strength Assessment

The TMAO-cardiovascular risk association is among the more robustly replicated gut microbiome-disease relationships in the literature. Multiple large independent prospective cohorts across different populations (cardiac patients, community-based adults) have shown consistent associations, and the mechanistic animal data aligns with human observations in a coherent pathway. The strength of evidence for dietary modification of TMAO is more modest — most intervention data comes from animal studies or short-term human trials. Mediterranean diet epidemiology provides indirect support, and the microbiome mechanistic work suggests plant-rich dietary patterns should reduce TMAO production, but long-term human RCT data on dietary TMAO modification and hard cardiovascular outcomes does not yet exist.

TMAO testing is becoming available as a clinical biomarker (Cleveland Clinic Laboratories offers a plasma TMAO assay), and may eventually complement traditional cardiovascular risk panels, particularly for patients with borderline traditional risk profiles.

References

Gut flora metabolism of phosphatidylcholine promotes cardiovascular diseaseWang Z, Klipfell E, Bennett BJ, Org E, Shea BS, Javaheri A, Garcia-Garcia JC, Levison BS, DiDonato JA, Hazen SL. Nature, 2011. PubMed 21475195 →
Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosisKoeth RA, Wang Z, Levison BS, Buffa JA, Org E, Sheehy BT, Britt EB, Fu X, Wu Y, Li L, Smith JD, DiDonato JA, Chen J, Li H, Wu GD, Lewis JD, Warrier M, Brown JM, Krauss RM, Tang WH, Bushman FD, Lusis AJ, Hazen SL. Nature Medicine, 2013. PubMed 23563705 →
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular riskTang WH, Wang Z, Levison BS, Koeth RA, Britt EB, Fu X, Wu Y, Hazen SL. New England Journal of Medicine, 2013. PubMed 23614584 →
Resveratrol attenuates trimethylamine-N-oxide (TMAO)-induced atherosclerosis by regulating TMAO synthesis and bile acid metabolism via remodeling of the gut microbiotaChen ML, Yi L, Zhang Y, Zhou X, Ran L, Yang J, Zhu JD, Zhang QY, Mi MT. mBio, 2016. PubMed 27048804 →
Plasma trimethylamine N-oxide (TMAO) levels predict future risk of coronary artery disease in apparently healthy individuals in the EPIC-Norfolk prospective population studyTang WH, Li XS, Wu Y, Wang Z, Khaw KT, Wareham NJ, Nieuwdorp M, Boekholdt SM, Hazen SL. American Heart Journal, 2021. PubMed 33626384 →